The first wide‐scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of auranofin and many additional drugs-Reference-Cited by-同舟云学术

The first wide‐scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of auranofin and many additional drugs

Published:2020-01-28 Issue:3 Volume:128 Page:242-250
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:APMIS

Author:

Foerster Sunniva¹²,Gustafsson Tomas N.³,Brochado Anna Rita²,Desilvestro Valentino⁴,Typas Athanasios²,Unemo Magnus¹

Affiliation:

1. WHO Collaborating Centre for Gonorrhoea and other STIs Department of Laboratory Medicine Faculty of Medicine and Health Örebro University Örebro Sweden

2. European Molecular Biology Laboratory (EMBL) Genome Biology Unit Heidelberg Germany

3. Department of Clinical Microbiology Sunderby Research Unit Umeå University Umeå Sweden

4. World Trade Institute (WTI) University of Bern Bern Switzerland

Funder

Universitetssjukhuset Örebro

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apm.13014

Reference37 articles.

1. Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines

2. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action

3. Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future

4. Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections

5. Drug repurposing: a better approach for infectious disease drug discovery?

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses;Journal of Autoimmunity;2024-09

2. Remapping the Chemical Space and the Pharmacological Space of Drugs: What Can We Expect from the Road Ahead?;Pharmaceuticals;2024-06-06

3. In vitro models for neuropathic pain phenotypic screening in brain therapeutics;Pharmacological Research;2024-04

4. Molecular mechanisms and clinical implications of the gold drug auranofin;Coordination Chemistry Reviews;2023-10

5. Drug repurposing in the context of common bacterial pathogens;Acta Biologica Szegediensis;2023-05-27